Inhaled corticosteroids in COPD: risk and benefits
- PMID: 34556555
- DOI: 10.1136/thoraxjnl-2021-217930
Inhaled corticosteroids in COPD: risk and benefits
Keywords: COPD pharmacology.
Conflict of interest statement
Competing interests: CJ has served in an advisory board and/or served as a speaker and/or participated in education arranged from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis, Chiesi, and TEVA. KL has served in an advisory board and/or served as a speaker and/or participated in education arranged by AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Novartis and Pfizer.
Comment on
-
Use of inhaled corticosteroids and risk of acquiring Pseudomonas aeruginosa in patients with chronic obstructive pulmonary disease.Thorax. 2022 Jun;77(6):573-580. doi: 10.1136/thoraxjnl-2021-217160. Epub 2021 Aug 26. Thorax. 2022. PMID: 34446524 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical